Protease-Activated Mechanisms in Inflammatory Bowel Disease

Proteases, a broad class of enzymes responsible for cleaving peptide bonds, play central roles in both the maintenance of intestinal homeostasis and the pathogenesis of inflammatory bowel disease (IBD). In health, tightly regulated proteolytic activity contributes to mucosal defence, barrier renewal and controlled immune signalling. In IBD, excessive or dysregulated protease action—whether from host cells or the gut microbiota—drives epithelial damage, increased permeability and chronic inflammation. Key protease families implicated include serine proteases, matrix metalloproteinases and host-derived thrombin, all of which modulate extracellular matrix integrity, tight-junction proteins and cytokine activation. Microbial proteases further amplify mucosal injury by altering mucin structure, activating pro-inflammatory receptors and disrupting immunoglobulin A. Recent advances have elucidated how specific bacterial species can either exacerbate or mitigate protease imbalance, opening avenues for targeted microbial and small-molecule therapies designed to restore proteolytic equilibrium. Together, these findings underscore protease-activated mechanisms as both drivers of tissue injury and promising points of therapeutic intervention in IBD.

Research from Nature Portfolio

New studies have identified commensal bacteria that directly regulate luminal proteolysis. One report demonstrated that members of the Paraprevotella genus recruit and degrade excess trypsin via a secretion-dependent surface machinery, thereby preserving immunoglobulin A integrity and enhancing resistance to enteric pathogens. This work highlights how selective enrichment of trypsin-degrading commensals may restore protease balance in the diseased gut. Complementing these findings, a proteomic analysis employing activity-based probes revealed that seven active serine proteases—including cathepsin G and thrombin—are markedly overactive in colonic secretions from IBD patients. By pinpointing proteases with elevated catalytic activity, this foundational approach has refined our understanding of enzyme targets driving mucosal breakdown and inflammatory cascades.

Protease-Activated Mechanisms in Inflammatory Bowel Disease publication trend

The graph below shows the total number of articles in protease-activated mechanisms in inflammatory bowel disease across all publications each year (not limited to Nature Index journals).

Technical terms

Protease: enzyme that hydrolyses peptide bonds in proteins and peptides.

Serine protease: subclass of proteases using a serine residue at the active site to cleave peptide bonds.

Matrix metalloproteinase (MMP): metal-dependent endopeptidase involved in degradation and remodelling of the extracellular matrix.

Luminal protease: proteolytic enzyme present within the intestinal lumen, derived from host or microbial sources.

Biofilm: structured community of microorganisms encased in a self-produced polymeric matrix adherent to a surface.

Activity-based probe: molecule that selectively binds to active enzymes, enabling their detection and functional profiling.

References

1. The emerging roles of bacterial proteases in intestinal diseases. Gut Microbes (2023).
2. Functional Proteomic Profiling of Secreted Serine Proteases in Health and Inflammatory Bowel Disease. Scientific Reports (2018).
3. Current understanding of the interplay between extracellular matrix remodelling and gut permeability in health and disease. Cell Death Discovery (2024).
4. Identification of trypsin-degrading commensals in the large intestine. Nature (2022).